IL156203A0 - Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders - Google Patents

Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Info

Publication number
IL156203A0
IL156203A0 IL15620303A IL15620303A IL156203A0 IL 156203 A0 IL156203 A0 IL 156203A0 IL 15620303 A IL15620303 A IL 15620303A IL 15620303 A IL15620303 A IL 15620303A IL 156203 A0 IL156203 A0 IL 156203A0
Authority
IL
Israel
Prior art keywords
carboxylic acid
treating
acid derivatives
psychiatric disorders
treating psychiatric
Prior art date
Application number
IL15620303A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Univ Ben Gurion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Univ Ben Gurion filed Critical Yissum Res Dev Co
Priority to IL15620303A priority Critical patent/IL156203A0/xx
Publication of IL156203A0 publication Critical patent/IL156203A0/xx
Priority to JP2006531007A priority patent/JP2007500205A/ja
Priority to PCT/IL2004/000455 priority patent/WO2004105746A1/en
Priority to AT04735084T priority patent/ATE409469T1/de
Priority to CA002527094A priority patent/CA2527094A1/en
Priority to EP04735084A priority patent/EP1626710B1/en
Priority to US10/558,408 priority patent/US20100048721A2/en
Priority to DE602004016841T priority patent/DE602004016841D1/de
Priority to IL172134A priority patent/IL172134A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15620303A 2003-05-29 2003-05-29 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders IL156203A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL15620303A IL156203A0 (en) 2003-05-29 2003-05-29 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
JP2006531007A JP2007500205A (ja) 2003-05-29 2004-05-27 精神障害を治療するための２，２，３，３，テトラメチルシクロプロパンカルボン酸誘導体の使用
PCT/IL2004/000455 WO2004105746A1 (en) 2003-05-29 2004-05-27 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
AT04735084T ATE409469T1 (de) 2003-05-29 2004-05-27 Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
CA002527094A CA2527094A1 (en) 2003-05-29 2004-05-27 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
EP04735084A EP1626710B1 (en) 2003-05-29 2004-05-27 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
US10/558,408 US20100048721A2 (en) 2003-05-29 2004-05-27 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
DE602004016841T DE602004016841D1 (de) 2003-05-29 2004-05-27 Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
IL172134A IL172134A (en) 2003-05-29 2005-11-23 Derivatives of 2,2,3,3 - Tetramethylcyclopropane carboxylic acid for the treatment of psychiatric diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15620303A IL156203A0 (en) 2003-05-29 2003-05-29 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Publications (1)

Publication Number Publication Date
IL156203A0 true IL156203A0 (en) 2003-12-23

Family

ID=32587598

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15620303A IL156203A0 (en) 2003-05-29 2003-05-29 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
IL172134A IL172134A (en) 2003-05-29 2005-11-23 Derivatives of 2,2,3,3 - Tetramethylcyclopropane carboxylic acid for the treatment of psychiatric diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL172134A IL172134A (en) 2003-05-29 2005-11-23 Derivatives of 2,2,3,3 - Tetramethylcyclopropane carboxylic acid for the treatment of psychiatric diseases

Country Status (8)

Country Link
US (1) US20100048721A2 (enExample)
EP (1) EP1626710B1 (enExample)
JP (1) JP2007500205A (enExample)
AT (1) ATE409469T1 (enExample)
CA (1) CA2527094A1 (enExample)
DE (1) DE602004016841D1 (enExample)
IL (2) IL156203A0 (enExample)
WO (1) WO2004105746A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
US20060004098A1 (en) * 2003-07-28 2006-01-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compounds useful for treating neurological disorders
CN100426897C (zh) 2005-01-12 2008-10-15 华为技术有限公司 分体式基站系统及其组网方法和基带单元
CN102198121B (zh) * 2011-04-08 2012-05-23 广东药学院 2,2,3,3-四甲基环丙酰硫脲在制备抗肿瘤药物中的应用
JP2014515408A (ja) * 2011-06-03 2014-06-30 エラン ファーマシューティカルズ，リミティド ライアビリティー カンパニー 行動及び精神障害の治療のためのシロ−イノシトール

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303274D0 (sv) * 1993-10-07 1993-10-07 Astra Ab Novel phenylethyl and phenylproplamines
IL108595A (en) * 1994-02-08 1998-09-24 Yissum Res Dev Co History of Carboxylic Acid 2,2,3,3 Tetramethyl Cyclophen (ACMT) (Process for their Preparation and Pharmaceutical Preparations Containing Them)
PL365588A1 (en) * 2000-07-21 2005-01-10 Teva Pharmaceutical Industries, Ltd. Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
IL147953A (en) * 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-

Also Published As

Publication number Publication date
JP2007500205A (ja) 2007-01-11
WO2004105746A1 (en) 2004-12-09
ATE409469T1 (de) 2008-10-15
US20100048721A2 (en) 2010-02-25
IL172134A0 (en) 2006-04-10
EP1626710A1 (en) 2006-02-22
EP1626710B1 (en) 2008-10-01
US20070043122A1 (en) 2007-02-22
IL172134A (en) 2011-02-28
CA2527094A1 (en) 2004-12-09
DE602004016841D1 (de) 2008-11-13

Similar Documents

Publication Publication Date Title
MXPA03006248A (es) Derivados de acido fumarico como inhibidores de nf-kappab.
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AP1498A (en) Inhibitors of impdh enzyme.
GEP20053631B (en) ) New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
IL154470A0 (en) Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
WO2004009549A3 (en) Piperidines useful for the treatment of central nervous system disorders
TW200613306A (en) Imidazotriazines as protein kinase inhibitors
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
DE60324183D1 (en) Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
DE60219595D1 (de) Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren
WO2001028996A3 (en) Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
MY142029A (en) Phenoxyacetic acid derivatives
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
IL193771A (en) Preparations that act as protein inhibitors deliver cholesterol ester
AU2002363182A1 (en) Smad7 inhibitors for the treatment of cns diseases
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
TW200621788A (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase Iε
IL156203A0 (en) Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
NO20061575L (no) Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
EP1597234A4 (en) NEW COMPOUNDS
GEP20033130B (en) Inhibitors of IMPDH Enzyme
EP1210948B8 (en) Therapeutic peptide for nervous diseases